Clinical trials
Phase 2 Lupus Nephritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 15 |
| Terminated | 11 |
| Unknown status | 9 |
| Not yet recruiting | 3 |
| Active, not recruiting | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Novartis Pharmaceuticals | 4 |
| Hoffmann-La Roche | 3 |
| Janssen Research & Development, LLC | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Aurinia Pharmaceuticals Inc. | 2 |
| Biogen | 2 |
| Boehringer Ingelheim | 2 |
| Children's Hospital Medical Center, Cincinnati | 2 |
| AbelZeta Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Nephritis | 65 |
| Lupus Erythematosus, Systemic | 20 |
| Glomerulonephritis | 5 |
| Glomerulonephritis, IGA | 5 |
| Glomerulonephritis, Membranous | 5 |
| Nephritis | 5 |
| Autoimmune Diseases | 4 |
| Kidney Diseases | 3 |
| Proteinuria | 3 |
| Glomerulonephritis, Membranoproliferative | 2 |
Trials
Showing 26 to 50 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.